Meta-Analysis: Faecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity

被引：0
|
作者：
Lin, Jin-Feng
Chen, Jin-Min
Nie, Biao
Jiang, Bo
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1225
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [41] Prognostic significance of serial faecal calprotectin in inflammatory bowel disease
    Zhulina, Y.
    Cao, Y.
    Amcoff, K.
    Carlson, M.
    Tysk, C.
    Halfvarson, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S315 - S318
  • [42] Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity A Systematic Review and Meta-Analysis
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    Cao, Qin
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (06) : 545 - 553
  • [43] The accuracy of fecal calprotectin for the diagnosis and assessment of disease activity in inflammatory bowel disease
    Saad, Abdo M.
    Chiorean, Michael V.
    Helper, Debra J.
    Galetti, Bridget D.
    Calley, Cynthia S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S424 - S424
  • [44] Intestinal Ultrasound Accurately Assesses Disease Activity in Inflammatory Bowel Disease When Compared to Faecal Calprotectin
    Heerasing, Neel
    Asthana, Anil
    Sparrow, Miles
    Jakobovits, Simon
    Gibson, Peter R.
    Friedman, Antony
    GASTROENTEROLOGY, 2016, 150 (04) : S441 - S441
  • [45] Minimal additional benefits in adding faecal haemoglobin to faecal calprotectin in predicting endoscopic disease activity in patients with inflammatory bowel disease
    Mak, L. -Y.
    Chen, L.
    Tong, T.
    Lau, S.
    Leung, W. -K.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S67 - S68
  • [46] Performance characteristics of faecal calprotectin testing for diagnosis of Inflammatory Bowel Disease
    Oyaert, M.
    Trouve, C.
    Baert, F.
    De Smet, D.
    Langlois, M.
    Vanpoucke, H.
    ACTA CLINICA BELGICA, 2014, 69 : 1 - 2
  • [47] The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease
    Zhulina, Y.
    Cao, Y.
    Amcoff, K.
    Carlson, M.
    Tysk, C.
    Halfvarson, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (05) : 495 - 504
  • [48] Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease
    Yamamoto, T.
    Shimoyama, T.
    Kuriyama, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (07) : 769 - 770
  • [49] Letter: faecal calprotectin, clinical indices and the diagnosis of inflammatory bowel disease
    Al Sulais, Eman
    AlAmeel, Turki
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1166 - 1166
  • [50] How to use faecal calprotectin in management of paediatric inflammatory bowel disease
    Saha, Amit
    Tighe, Mark P.
    Batra, Akshay
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2016, 101 (03): : 124 - 128
12345